The prediction study of the effect of antibody therapy using antibody dependent cell-mediated cytotoxicity with blood sample
Not Applicable
- Conditions
- malignant solid tumor
- Registration Number
- JPRN-UMIN000002320
- Lead Sponsor
- national cancer center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
* patients determined ineligible for this study by the researcher
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method